Adrichem, Rik
Mattace-Raso, A. Maarten
Hokken, Thijmen W.
van den Dorpel, Mark M. P.
de Ronde, Marjo J. A. G.
Lenzen, Mattie J.
Cummins, Paul A.
Kardys, Isabella
Nuis, Rutger-Jan
Daemen, Joost
Bekkers, Jos A.
Van Mieghem, Nicolas M.
Article History
Accepted: 1 July 2024
First Online: 20 August 2024
Conflicts of interest
: R. Adrichem, A. M. Mattace-Raso, T.W. Hokken, M.M.P. van den Dorpel, M.J.A.G. de Ronde, M.J. Lenzen, P.A. Cummins, I. Kardys, R.-J. Nuis, and J.A. Bekkers declare that they have no competing interests. N.M. Van Mieghem has received research grant support from Abbott Vascular, Boston Scientific, Biotronik, Edwards Lifesciences, Medtronic, Pulsecath BV, Abiomed and Daiichi Sankyo, and consultancy and speaker fees from Jenavalve, Daiichi Sankyo, Abbott Vascular, Boston Scientific, Medtronic, Abiomed and Amgen. J. Daemen received institutional grant/research support from Abbott Vascular, Boston Scientific, ACIST Medical, Medtronic, Microport, Pie Medical and ReCor Medical, and consultancy and speaker fees from Abbott Vascular, Abiomed, ACIST Medical, Boston Scientific, Cardialysis BV, CardiacBooster, Kaminari Medical, ReCor Medical, PulseCath, Pie Medical, Sanofi, Siemens Health Care and Medtronic.